Tokyo, July 4, 2006 (JCN) - Trans Genic has announced that it has obtained a Japanese patent (JP3816512) on a high-sensitive immunological assay system for cancer diagnosis from the japan Patent Office. The patented method, which uses anti-diacetylspermine antibodies and urine samples, can diagnose early stage cancer in a simplified and noninvasive manner.
